Regulatory Affairs Director
Seagen
Shaila Choi MSc, CSci, MTOPRA, Regulatory Affairs Director, Seagen GmBH
Over 15 years of experience in delivering regulatory strategies and operations for drug development in a diverse range of products, most recently focussing on Oncology. Shaila is a subject matter expert on global clinical trials and the EU Clinical Trial Regulation 536/2014
Disclosure information not submitted.
Monday, September 12, 2022
2:00 PM – 3:00 PM MST